Can Claritin (loratadine) cause drowsiness?

Claritin Does Not Cause Drowsiness at Recommended Doses

Loratadine (Claritin) does not cause sedation when taken at the recommended dose of 10 mg daily 1. The FDA-approved labeling explicitly markets it as "Non-Drowsy" 2, and this claim is supported by rigorous clinical evidence.

Evidence-Based Sedation Profile

At Recommended Doses (10 mg daily)

Multiple studies demonstrate that loratadine at 10 mg daily shows no sedative properties compared to placebo 1. This has been confirmed through:

• Objective performance testing: No impairment in reaction time, vigilance, digit symbol substitution, or symbol copying tasks 3
• Sleep latency studies: No reduction in time to fall asleep compared to placebo 3
• Actual driving performance: Effects comparable to placebo 4
• Self-reported drowsiness: Rates similar to placebo (10 patients on loratadine vs 8 on placebo in one study) 5

The guideline evidence explicitly states that fexofenadine, loratadine, and desloratadine "do not cause sedation at recommended doses" 1.

Important Caveats and Exceptions

Loratadine CAN cause drowsiness in two specific situations:

1. Doses exceeding the recommended amount: When dosed higher than 10 mg daily, loratadine may develop sedative properties 1

2. Patients with low body mass: Individuals with low body weight receiving standard age-based dosing may reach elevated drug levels (on a mg/kg basis), potentially developing drowsiness and performance impairment 1

Clinical Comparison

Loratadine is fundamentally different from first-generation antihistamines like diphenhydramine, which cause significant drowsiness, impaired driving performance, and reduced work productivity 1. In head-to-head studies, diphenhydramine significantly reduced sleep latency and impaired performance, while loratadine 10 mg and even 40 mg doses showed no such effects 3.

Among second-generation antihistamines, loratadine has a more favorable sedation profile than cetirizine (Zyrtec), which may cause mild drowsiness in 13.7% of patients versus 6.3% with placebo 1.

Practical Recommendations

• Reassure patients: Loratadine at 10 mg daily is appropriately labeled as non-drowsy and should not impair daily activities, driving, or work performance
• Avoid exceeding recommended doses: Do not increase beyond 10 mg daily if concerned about sedation
• Consider body weight: In patients with very low body mass, monitor for unexpected drowsiness
• If sedation occurs: This is unusual at standard doses; consider switching to fexofenadine, which shows no sedation even at higher-than-recommended doses 1

The evidence consistently supports that loratadine is a truly non-sedating antihistamine when used as directed 6, 4.